Literature DB >> 20410234

New insights into thyroglobulin pathophysiology revealed by the study of a family with congenital goiter.

D Peteiro-Gonzalez1, J Lee, J Rodriguez-Fontan, I Castro-Piedras, J Cameselle-Teijeiro, A Beiras, S B Bravo, C V Alvarez, D M Hardy, H M Targovnik, P Arvan, J Lado-Abeal.   

Abstract

CONTEXT: Thyroglobulin (TG) gene mutations cause congenital hypothyroidism (CH) with goiter. A founder effect has been proposed for some frequent mutations. Mutated proteins have a defect in intracellular transport causing intracellular retention with ultrastructural changes that resemble an endoplasmic reticulum storage disease.
OBJECTIVE: To reveal new aspects of thyroglobulin pathophysiology through clinical, cellular, molecular, and genetic studies in a family presenting with CH due to TG mutations from Galicia, an iodine-deficient area of Spain.
DESIGN: The included clinical evaluation of family members, DNA sequencing for TG gene mutation and haplotyping analysis, ultrastructural analysis of thyroid tissue specimens from affected subjects, analysis of effects of mutations found on TG gene transcription, and in vitro studies of cellular production and secretion of mutated proteins.
SETTING: Locations included primary care and university hospitals.
RESULTS: Family members with CH, mental retardation, and goiter were compound heterozygous for c.886C-->T (p.R277X) and g.IVS35+1delG. For c.886C-->T, a founder effect cannot be excluded, and its transcription was hardly detectable. g.IVS35+1delG caused an in-frame deletion in exon 35 and produced a protein that, although synthesized, could not be secreted. Ultrastructural analyses showed morphological changes consistent with an endoplasmic reticulum storage disease.
CONCLUSION: The shorter thyroglobulin resulting from the novel g.IVS35+1delG was retained within the endoplasmic reticulum of thyrocytes, and together with p.R227X caused severe hypothyroidism with goiter. p.R277X, the most commonly described TG mutation, is caused by a TG exon-7 highly mutation-prone region, and the possibility that some cases were introduced to South America from Galicia cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20410234      PMCID: PMC2928901          DOI: 10.1210/jc.2009-2109

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

1.  Genomic organization of the human thyroglobulin gene: the complete intron-exon structure.

Authors:  F M Mendive; C M Rivolta; C M Moya; G Vassart; H M Targovnik
Journal:  Eur J Endocrinol       Date:  2001-10       Impact factor: 6.664

2.  A premature stopcodon in thyroglobulin messenger RNA results in familial goiter and moderate hypothyroidism.

Authors:  S A van de Graaf; C Ris-Stalpers; G J Veenboer; M Cammenga; C Santos; H M Targovnik; J J de Vijlder; G Medeiros-Neto
Journal:  J Clin Endocrinol Metab       Date:  1999-07       Impact factor: 5.958

3.  Congenital hypothyroid goiter with deficient thyroglobulin. Identification of an endoplasmic reticulum storage disease with induction of molecular chaperones.

Authors:  G Medeiros-Neto; P S Kim; S E Yoo; J Vono; H M Targovnik; R Camargo; S A Hossain; P Arvan
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

4.  Defective thyroglobulin export as a cause of congenital goitre.

Authors:  S Lissitzky; J Torresani; G N Burrow; S Bouchilloux; O Chabaud
Journal:  Clin Endocrinol (Oxf)       Date:  1975-07       Impact factor: 3.478

5.  The structure and properties of 27S and larger iodoproteins in the thyroid gland.

Authors:  G Berg; U Björkman
Journal:  Biochim Biophys Acta       Date:  1975-09-09

6.  Neighboring-nucleotide effects on the rates of germ-line single-base-pair substitution in human genes.

Authors:  M Krawczak; E V Ball; D N Cooper
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

7.  Two distinct compound heterozygous constellations (R277X/IVS34-1G>C and R277X/R1511X) in the thyroglobulin (TG) gene in affected individuals of a Brazilian kindred with congenital goiter and defective TG synthesis.

Authors:  Viviana J Gutnisky; Christian M Moya; Carina M Rivolta; Sabina Domené; Viviana Varela; Jussara V Toniolo; Geraldo Medeiros-Neto; Héctor M Targovnik
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

8.  Primary structure of bovine thyroglobulin deduced from the sequence of its 8,431-base complementary DNA.

Authors:  L Mercken; M J Simons; S Swillens; M Massaer; G Vassart
Journal:  Nature       Date:  1985 Aug 15-21       Impact factor: 49.962

9.  The p.A2215D thyroglobulin gene mutation leads to deficient synthesis and secretion of the mutated protein and congenital hypothyroidism with wide phenotype variation.

Authors:  Viviane Pardo; Jussara Vono-Toniolo; Ileana G S Rubio; Meyer Knobel; Roberta F Possato; Hector M Targovnik; Peter Kopp; Geraldo Medeiros-Neto
Journal:  J Clin Endocrinol Metab       Date:  2009-06-09       Impact factor: 5.958

10.  An endoplasmic reticulum storage disease causing congenital goiter with hypothyroidism.

Authors:  P S Kim; O Y Kwon; P Arvan
Journal:  J Cell Biol       Date:  1996-05       Impact factor: 10.539

View more
  4 in total

1.  Clinical, biochemical, and molecular findings in Argentinean patients with goitrous congenital hypothyroidism.

Authors:  Ana Chiesa; Carina M Rivolta; Héctor M Targovnik; Laura Gruñeiro-Papendieck
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

2.  Repeat motif-containing regions within thyroglobulin.

Authors:  Jaemin Lee; Peter Arvan
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

3.  Neck mass: an obstructive cause of respiratory distress with medical management.

Authors:  Vijay Singh; Aakash Pandita; Girish Gupta; Amit Shukla
Journal:  BMJ Case Rep       Date:  2017-12-02

Review 4.  Thyroglobulin From Molecular and Cellular Biology to Clinical Endocrinology.

Authors:  Bruno Di Jeso; Peter Arvan
Journal:  Endocr Rev       Date:  2015-11-23       Impact factor: 19.871

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.